Incidence of BRCA1/2 germ line alterations in a high risk cohort participating in a phase II chemoprevention trial - Klemp, J; Brady, D; Frank, T.S; Kimler, B.F; Fabian, C.J (European journal of cancer (1990), 2000)
Keywords: Adult; Antineoplastic Agents - therapeutic use; BRCA mutation; BRCA2 gene; BRCA2 Protein; Breast Neoplasms - genetics; Breast Neoplasms - prevention & control; chemoprevention; Cohort Studies; difluromethylornithine; Eflornithine - therapeutic use; Female; Genes, BRCA1 - genetics; Germ-Line Mutation - genetics; Humans; Middle Aged; Neoplasm Proteins - genetics; Pedigree; Prevention trial; Risk Factors; Transcription Factors - genetics; Prevention trial; BRCA mutation